Bora, a contract development and manufacturing organization (CDMO) that specializes in modified release (MR) and solvent production, has reported a successful FDA general inspection for its facility in Zhunan, Taiwan.   The publicly listed company recently hosted the site’s fifth successful inspection by the U.S. regulatory body of its global supply facility located south-west of Taipei, with zero 483 observations.   The oral solid expert is Taiwan’s biggest CDMO, responsible for producing 52% o...